These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 16455054)

  • 21. Effects of phosphodiesterase 5 inhibitor on pulmonary vascular reactivity in the fetal lamb.
    Jaillard S; Larrue B; Deruelle P; Delelis A; Rakza T; Butrous G; Storme L
    Ann Thorac Surg; 2006 Mar; 81(3):935-42. PubMed ID: 16488698
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Compartmentalization of cardiac beta-adrenergic inotropy modulation by phosphodiesterase type 5.
    Takimoto E; Belardi D; Tocchetti CG; Vahebi S; Cormaci G; Ketner EA; Moens AL; Champion HC; Kass DA
    Circulation; 2007 Apr; 115(16):2159-67. PubMed ID: 17420342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Profiling of functional phosphodiesterase in mesangial cells using a CRE-SEAP-based reporting system.
    Zhu Y; Yao J; Meng Y; Kasai A; Hiramatsu N; Hayakawa K; Miida T; Takeda M; Okada M; Kitamura M
    Br J Pharmacol; 2006 Jul; 148(6):833-44. PubMed ID: 16751794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of cAMP and cGMP-phosphodiesterase isoenzymes 3, 4, and 5 in the human clitoris: immunohistochemical and molecular biology study.
    Oelke M; Hedlund P; Albrecht K; Ellinghaus P; Stief CG; Jonas U; Andersson KE; Uckert S
    Urology; 2006 May; 67(5):1111-6. PubMed ID: 16635522
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Negative feedback in NO/cGMP signalling.
    Koesling D; Mullershausen F; Lange A; Friebe A; Mergia E; Wagner C; Russwurm M
    Biochem Soc Trans; 2005 Nov; 33(Pt 5):1119-22. PubMed ID: 16246060
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclic nucleotide phosphodiesterase 1C promotes human arterial smooth muscle cell proliferation.
    Rybalkin SD; Rybalkina I; Beavo JA; Bornfeldt KE
    Circ Res; 2002 Feb; 90(2):151-7. PubMed ID: 11834707
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phosphodiesterase inhibitors in airways disease.
    Fan Chung K
    Eur J Pharmacol; 2006 Mar; 533(1-3):110-7. PubMed ID: 16458289
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ANP-mediated cGMP signaling and phosphodiesterase inhibition in the rat cervical spinal cord.
    de Vente J; Markerink-van Ittersum M; Vles JS
    J Chem Neuroanat; 2006 Jun; 31(4):263-74. PubMed ID: 16621444
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Phosphodiesterase type 5 siRNA increases cGMP in the smooth muscle cells of human corpus cavernosum].
    Chen GQ; Bai WJ; Wang XF; Liu SJ; He PY; Hou SK
    Zhonghua Nan Ke Xue; 2006 Nov; 12(11):979-81, 984. PubMed ID: 17146920
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phosphodiesterase 1 upregulation in pulmonary arterial hypertension: target for reverse-remodeling therapy.
    Schermuly RT; Pullamsetti SS; Kwapiszewska G; Dumitrascu R; Tian X; Weissmann N; Ghofrani HA; Kaulen C; Dunkern T; Schudt C; Voswinckel R; Zhou J; Samidurai A; Klepetko W; Paddenberg R; Kummer W; Seeger W; Grimminger F
    Circulation; 2007 May; 115(17):2331-9. PubMed ID: 17438150
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Desensitization of NO/cGMP signaling in smooth muscle: blood vessels versus airways.
    Mullershausen F; Lange A; Mergia E; Friebe A; Koesling D
    Mol Pharmacol; 2006 Jun; 69(6):1969-74. PubMed ID: 16510560
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of the PDE5 enzyme on human retinal tissue: new aspects of PDE5 inhibitors ocular side effects.
    Foresta C; Caretta N; Zuccarello D; Poletti A; Biagioli A; Caretti L; Galan A
    Eye (Lond); 2008 Jan; 22(1):144-9. PubMed ID: 17585311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tadalafil, a long-acting type 5 phosphodiesterase isoenzyme inhibitor, improves neurological functional recovery in a rat model of embolic stroke.
    Zhang L; Zhang Z; Zhang RL; Cui Y; LaPointe MC; Silver B; Chopp M
    Brain Res; 2006 Nov; 1118(1):192-8. PubMed ID: 16959227
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Time-dependent involvement of cAMP and cGMP in consolidation of object memory: studies using selective phosphodiesterase type 2, 4 and 5 inhibitors.
    Rutten K; Prickaerts J; Hendrix M; van der Staay FJ; Sik A; Blokland A
    Eur J Pharmacol; 2007 Mar; 558(1-3):107-12. PubMed ID: 17207788
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Celecoxib dilates guinea-pig coronaries and rat aortic rings and amplifies NO/cGMP signaling by PDE5 inhibition.
    Klein T; Eltze M; Grebe T; Hatzelmann A; Kömhoff M
    Cardiovasc Res; 2007 Jul; 75(2):390-7. PubMed ID: 17383621
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The GAF domain of the cGMP-binding, cGMP-specific phosphodiesterase (PDE5) is a sensor and a sink for cGMP.
    Biswas KH; Sopory S; Visweswariah SS
    Biochemistry; 2008 Mar; 47(11):3534-43. PubMed ID: 18293931
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of phosphodiesterase 5 in maternal and fetal sheep.
    Coppage KH; Sun X; Baker RS; Clark KE
    Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 2):1005-10. PubMed ID: 16157102
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New pyrazolo[1',5':1,6]pyrimido[4,5-d]pyridazin-4(3H)-ones as potent and selective PDE5 inhibitors.
    Feixas J; Giovannoni MP; Vergelli C; Gavaldà A; Cesari N; Graziano A; Dal Piaz V
    Bioorg Med Chem Lett; 2005 May; 15(9):2381-4. PubMed ID: 15837329
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overview of PDEs and their regulation.
    Omori K; Kotera J
    Circ Res; 2007 Feb; 100(3):309-27. PubMed ID: 17307970
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Specific localized expression of cGMP PDEs in Purkinje neurons and macrophages.
    Bender AT; Beavo JA
    Neurochem Int; 2004 Nov; 45(6):853-7. PubMed ID: 15312979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.